Parenteral Drug Association
FDANonrulemakingFDA-2009-D-0001

Draft Guidance for Industry on Standards for Securing the Drug Supply Chain -- Standardized Numerical Identification for Prescription Drug Packages; Availability

RIN
Last modified
Jan 5, 2022
Comment window
closed 6312d ago
Parenteral Drug Association filings
1

Activity

Parenteral Drug Association filed 1 comment on this docket between Apr 15, 2009 and Apr 15, 2009. 17 other organizations filed here. The comment window closed 6312d ago.

What Parenteral Drug Association filed (1)

Apr 15, 2009· Parenteral Drug Association (PDA) - Comment· FDA-2009-D-0001-0027

PDA is pleased to offer comments on the FDA Draft Guidance for Industry on Standards for Securing the Drug Supply Chain – Standardized Numerical Identification for Prescription Drug Packages. PDA is a non-profit international professional association of more than 11,000 individual member scientists having an interest in the fields of pharmaceutical, biological, and device manufacturing and quality. Our comments were prepared by a committee of experts with experience in supply chain issues including members representing our Regulatory Affairs and Quality Committee. PDA wishes to thank the FDA for the opportunity to offer comments on this Draft Guidance.

Abstract

No abstract recorded.

View on regulations.gov →
Draft Guidance for Industry on Standards for Securing the Drug Supply Chain -- Standardized Numerical Identification for Prescription Drug Packages; Availability (FDA) — Parenteral Drug Association | OpenPolis